ENDS 2020 conference has been postponed. Find out more

A letter from Advisory Board member Ian Fearon of whatIF? Consulting Limited

Save the date for this year’s ENDS Conference 2019, which will be held June 4-6, in London, United Kingdom!  On behalf of the conference’s Advisory Board*, I would like to inform you about the theme and developing program of this year’s conference. 

A fantastic line-up of speakers will share their insights with you including; MHRA, Department of Health and Social Care, Ecig Intelligence, Broughton Nicotine Services, Public Health England, UKVIA and many more. As Europe’s leading conference to cover scientific, regulatory and commercial developments in ENDS, it is truly unmissable for anyone working within this sector.

In addition to the exciting programme, we have also organised a pre-conference flavours workshop on 4 June, which will give you the exclusive opportunity to hear the latest science behind e-cigarette flavours, assess regulatory issues, and find out how flavours will play out commercially going forward. Workshop speakers include Cuts Ice, New Nicotine Alliance, Flavour Core, MI Vape and Hall Analytical.

Why should you attend?

The ENDS conference brings together leaders from across the world in e-cigarette regulation, science, product design and marketing.  This is a unique environment in which to either bring someone up to speed in these areas, or hear about the latest developments for those already familiar with this space.

The e-cigarette marketplace is an ever-changing environment.  Not only do we have product innovation, but how the products are being regulated globally is constantly shifting. Many of the speakers are well versed in current and upcoming regulatory changes that will affect e-cigarette manufacturers, and the opportunity of hearing them discuss how these changes will affect manufacturers will help their preparation for the future.

A salient feature of the conference format is that it utilises different styles of presenting information which make it easy to just listen and learn, or to question the speakers and panellists in both formal and informal environments.  Furthermore, audience participation in this conference is always strong, meaning that attendees learn from each other as well as from the speakers.

Who should attend?

Product manufacturers – to ensure they are up to speed with regulatory developments globally and that their businesses are prepared for upcoming changes

Scientists – to hear about the latest advances in our understanding of the scientific basis for e-cigarettes and tobacco harm reduction.

Regulators – this conference offers engagement opportunities with product manufacturers and scientists advancing our understanding of e-cigarettes. Such engagement is greatly beneficial to developing effective regulation for the benefit of smokers who need to switch to a less harmful alternative.

I look forward to seeing old friends and making new ones at ENDS Conference 2019 in London this June.  You can book your place at the Standard rate of just £1,199 to join me here. 

Best regards,

Ian Fearon
whatIF? Consulting Limited
ENDS Conference Advisory Board Member

* ENDS Conference 2019 Advisory Board:  Ian Fearon, Consultant, whatIF? Consulting Limited; Dr. Andrew Feilden, Chemistry Operations Director, Smithers Rapra; Scott Fletcher, Director of Analytical Services, Hall Analytical; Liam Humberstone, Technical Director at Totally Wicked, Product Design & Engineering at Independent British Vape Trade Association (IBVTA); Patricia I. Kovacevic, Global Legal and Regulatory Strategist, Independent Company; Ian Tindall, Head of Innovation and Marketing, Cerulean

  • Ian Fearon

    Consultant whatIF? Consulting Limited

    Ian is an independent consultant with expertise in regulatory and scientific aspects of nicotine and tobacco products. Ian most recently worked for JUUL Labs as Senior Director of Clinical and Regulatory Affairs EMEA, and previously he was Director of Tobacco Research at Celerion, a provider of clinical research capabilities and expertise to the tobacco and e-cigarette industry. Prior to that, Ian was Principal Scientist and Head of Clinical Research at British American Tobacco's central research and development centre in Southampton, U.K. He specializes in the biological and psychological effects of nicotine, clinical and pre-clinical studies to assess the biological effects of electronic cigarettes and tobacco heating devices, and the scientific basis for regulation.  Prior to working in the industry, Ian pursued an academic career as a Lecturer in Physiology at the University of Manchester and an Assistant Professor in Biology at McMaster University in Hamilton, Canada.  Ian is a highly-cited scientific researcher and writer, contributing to more than 50 peer-reviewed papers and book chapters which have generated over 2,400 citations.